The Oncologic Drugs Advisory Committee (ODAC) receives requests for technical and clinical evaluation of new drugs by the U.S. Food and Drug Administration (FDA).
The Oncologic Drugs Advisory Committee (ODAC) handles requests for technical and clinical assessments of new drugs, as does the U.S. Food and Drug Administration (FDA).